 |
diacetyl(N(4)-methylthiosemicarbazonato) copper (II) |
|---|---|
| Trade Name | |
| Orphan Indication | Amyotrophic lateral sclerosis |
| USA Market Approval | USA |
| USA Designation Date | 2017-12-18 00:00:00 |
| Sponsor | Collaborative Medicinal Development Pty. Ltd. (CMD);c/o Shaw Downie, Level 11;Sydney |
